Literature DB >> 17703270

Relationships between insulin-like growth factor-I (IGF-I) and OPG, RANKL, bone mineral density in healthy Chinese women.

H-Y Zhao1, J-M Liu, G Ning, Y-J Zhao, Y Chen, L-H Sun, L-Z Zhang, M-Y Xu, J-L Chen.   

Abstract

UNLABELLED: Serum IGF-I level was negatively correlated with OPG and OPG/RANKL ratio, but positively correlated with RANKL. Serum OPG level in the highest quintile of IGF-I was significantly lower than that in the lowest. We conclude that the effect of IGF-I on bone remodeling may be mediated by the OPG/RANKL system.
INTRODUCTION: Insulin-like growth factor I (IGF-I) is an important factor in coupling bone remodeling, activating both formation and resorption. Compared with the many studies on the role of IGF-I in bone formation, the information regarding its effects on bone resorption is limited and conflicting. The balance of the two peptides produced by osteoblasts, osteoprotegerin (OPG) and receptor activator of nuclear factor-kappaB ligand (RANKL), is critical for the bone resorption process. Our study was designed to analyze the relationships of serum concentrations of IGF-I with OPG, RANKL, OPG/RANKL ratio as well as BMDs in healthy Chinese women.
METHODS: BMDs at lumbar spine and proximal femur in 504 pre- and postmenopausal women were measured by DXA. Serum levels of IGF-I, OPG and RANKL were also measured. Pearson's correlation and partial correlation analysis, ANOVA, covariance analysis and stepwise multiple regression analysis were used as appropriate.
RESULTS: Age was negatively correlated with serum levels of IGF-I (r = -0.702, p < 0.001). IGF-I was negatively correlated with OPG and OPG/RANKL ratio, but positively correlated with RANKL. The relationship between IGF-I and BMDs disappeared after adjustment for age. In postmenopausal women, IGF-I was lower in women with osteoporosis than in those with normal BMD (p = 0.056), but no differences were found among OPG, RANKL and OPG/RANKL ratio. Serum levels of OPG in the highest quintile of IGF-I were significantly lower than those in the lowest quintile of IGF-I, while no difference was found in RANKL. In the multiple regression analysis model, serum levels of IGF-I were the main determinants of the bone mass in Chinese women.
CONCLUSIONS: In conclusion, the relationship between decreasing IGF-I and BMDs in healthy Chinese women influenced by age, whereas the effect of IGF-I on bone remodeling (bone resorption) may be mediated by the OPG/RANKL system.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17703270     DOI: 10.1007/s00198-007-0440-y

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  33 in total

1.  Evidence that anabolic effects of PTH on bone require IGF-I in growing mice.

Authors:  N Miyakoshi; Y Kasukawa; T A Linkhart; D J Baylink; S Mohan
Journal:  Endocrinology       Date:  2001-10       Impact factor: 4.736

2.  Age-related changes in insulin-like growth factor I and II in human femoral cortical bone: lack of correlation with bone mass.

Authors:  T Seck; A Bretz; R Krempien; B Krempien; R Ziegler; J Pfeilschifter
Journal:  Bone       Date:  1999-04       Impact factor: 4.398

3.  Serum levels of insulin-like growth factor (IGF) I, IGF-binding protein (IGFBP)-2, and IGFBP-3 in osteoporotic patients with and without spinal fractures.

Authors:  T Sugimoto; K Nishiyama; F Kuribayashi; K Chihara
Journal:  J Bone Miner Res       Date:  1997-08       Impact factor: 6.741

4.  Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.

Authors:  W S Simonet; D L Lacey; C R Dunstan; M Kelley; M S Chang; R Lüthy; H Q Nguyen; S Wooden; L Bennett; T Boone; G Shimamoto; M DeRose; R Elliott; A Colombero; H L Tan; G Trail; J Sullivan; E Davy; N Bucay; L Renshaw-Gegg; T M Hughes; D Hill; W Pattison; P Campbell; S Sander; G Van; J Tarpley; P Derby; R Lee; W J Boyle
Journal:  Cell       Date:  1997-04-18       Impact factor: 41.582

Review 5.  From mouse to man: redefining the role of insulin-like growth factor-I in the acquisition of bone mass.

Authors:  Shoshana Yakar; Clifford J Rosen
Journal:  Exp Biol Med (Maywood)       Date:  2003-03

6.  Characterization of osteoprotegerin binding to glycosaminoglycans by surface plasmon resonance: role in the interactions with receptor activator of nuclear factor kappaB ligand (RANKL) and RANK.

Authors:  S Théoleyre; S Kwan Tat; P Vusio; F Blanchard; J Gallagher; S Ricard-Blum; Y Fortun; M Padrines; F Rédini; D Heymann
Journal:  Biochem Biophys Res Commun       Date:  2006-06-30       Impact factor: 3.575

7.  Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation.

Authors:  S K Lee; J A Lorenzo
Journal:  Endocrinology       Date:  1999-08       Impact factor: 4.736

8.  Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function.

Authors:  P A Hill; J J Reynolds; M C Meikle
Journal:  Endocrinology       Date:  1995-01       Impact factor: 4.736

9.  Insulin-like growth factors I and II in healthy women with and without established osteoporosis.

Authors:  P Ravn; K Overgaard; E M Spencer; C Christiansen
Journal:  Eur J Endocrinol       Date:  1995-03       Impact factor: 6.664

10.  Leptin reduces ovariectomy-induced bone loss in rats.

Authors:  B Burguera; L C Hofbauer; T Thomas; F Gori; G L Evans; S Khosla; B L Riggs; R T Turner
Journal:  Endocrinology       Date:  2001-08       Impact factor: 4.736

View more
  14 in total

1.  The effect of 12 weeks of resistance training on hormones of bone formation in young sedentary women.

Authors:  Mehrzad Moghadasi; Sadri Siavashpour
Journal:  Eur J Appl Physiol       Date:  2012-05-05       Impact factor: 3.078

Review 2.  Therapies for musculoskeletal disease: can we treat two birds with one stone?

Authors:  Christian M Girgis; Nancy Mokbel; Douglas J Digirolamo
Journal:  Curr Osteoporos Rep       Date:  2014-06       Impact factor: 5.096

3.  The effect of oral contraceptive different patterns of use on circulating IGF-1 and bone mineral density in healthy premenopausal women.

Authors:  Amany Y Elkazaz; Khaled Salama
Journal:  Endocrine       Date:  2014-05-27       Impact factor: 3.633

Review 4.  Levels of osteoprotegerin (OPG) and receptor activator for nuclear factor kappa B ligand (RANKL) in serum: are they of any help?

Authors:  Doris Wagner; Astrid Fahrleitner-Pammer
Journal:  Wien Med Wochenschr       Date:  2010-08-16

5.  Association of JAG1 with bone mineral density and osteoporotic fractures: a genome-wide association study and follow-up replication studies.

Authors:  Annie W C Kung; Su-Mei Xiao; Stacey Cherny; Gloria H Y Li; Yi Gao; Gloria Tso; Kam S Lau; Keith D K Luk; Jian-min Liu; Bin Cui; Min-Jia Zhang; Zhen-lin Zhang; Jin-wei He; Hua Yue; Wia-bo Xia; Lian-mei Luo; Shu-li He; Douglas P Kiel; David Karasik; Yi-Hsiang Hsu; L Adrienne Cupples; Serkalem Demissie; Unnur Styrkarsdottir; Bjarni V Halldorsson; Gunnar Sigurdsson; Unnur Thorsteinsdottir; Kari Stefansson; J Brent Richards; Guangju Zhai; Nicole Soranzo; Ana Valdes; Tim D Spector; Pak C Sham
Journal:  Am J Hum Genet       Date:  2010-01-21       Impact factor: 11.025

Review 6.  Growth hormone, insulin-like growth factors, and the skeleton.

Authors:  Andrea Giustina; Gherardo Mazziotti; Ernesto Canalis
Journal:  Endocr Rev       Date:  2008-04-24       Impact factor: 19.871

7.  IGF-1 as an early marker for low bone mass or osteoporosis in premenopausal and postmenopausal women.

Authors:  Jian-min Liu; Hong-yan Zhao; Guang Ning; Ying Chen; Lian-zhen Zhang; Li-hao Sun; Yong-ju Zhao; Man-yin Xu; Jia-lun Chen
Journal:  J Bone Miner Metab       Date:  2008-02-27       Impact factor: 2.626

Review 8.  Receptor activator of nuclear factor-κB ligand and osteoprotegerin: maintaining the balance to prevent bone loss.

Authors:  Anne-Priscille Trouvin; Vincent Goëb
Journal:  Clin Interv Aging       Date:  2010-11-19       Impact factor: 4.458

9.  Antiosteoporotic Activity of Dioscorea alata L. cv. Phyto through Driving Mesenchymal Stem Cells Differentiation for Bone Formation.

Authors:  Kang-Yung Peng; Lin-Yea Horng; Hui-Ching Sung; Hui-Chuan Huang; Rong-Tsun Wu
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-29       Impact factor: 2.629

10.  Relationship of insulin-like growth factor 1 and bone parameters in 7-15 years old apparently, healthy Indian children.

Authors:  Veena H Ekbote; Vaman V Khadilkar; Anuradha V Khadilkar; Zulf Mughal; Shashi A Chiplonkar; Sonal A Palande; Supriya S Phanse-Gupte; Vivek G Patwardhan; Dhanashri S Shilvant
Journal:  Indian J Endocrinol Metab       Date:  2015 Nov-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.